Experimental Cancer Medicine Centres develop new cancer therapies. Jointly funded @CR_UK @LPTrustUK @NIHRresearch @CSO_Scotland @ResearchWales @BelfastTrust
Amazing to see Prof. Caroline Dive (@ECMC_Manchester) mentoring at this evening's @AACR Professional Development Session — sharing her expertise and championing career growth #Mentorship#AACR2025
It was fantastic to see Dr. Frankie Fan, Prof. Karen Brown (Leicester ECMC) and their incredible colleagues at #AACR2025! sharing insights on clinical trial recruitment barriers in colorectal polyp prevention in today's late-breaking poster session.
We're listening to a fascinating update on GLIMPS (IL13R CAR-T for high-grade glioma) and MIGHTY (Multi-modular CAR-T cells targeting B7-H3 in CYP sarcoma) by Dr Karin Straathof @UCL_ECMC
We're continuing in the #CCLG2025's Clinical Trials (Solid & CNS Tumours session) with @Newcastle_ECMC's Dr. Quentin Campbell-Hewson for an exciting update on the New Agents Group!
Dr John Apps (@ECMCBham) is now presenting a Phase II trial of carboplatin or vinblastine monotherapy induction prior to radiotherapy for intracranial germinoma. Looking forward to an insightful afternoon with updates on exciting advancements for paediatric solid & CNS tumours!
Prof. Darren Hargrave @UCL_ECMC is presenting during this session providing a UKCCCR & NIHR Brain Tumour Therapeutics Consortium update and the epilogue of the Phase I/II combination trial in relapsed paediatric low-grade glioma.
🔬 We're now attending the Clinical Trials (Solid & CNS Tumours) session, chaired by Prof. Amos Burke @ECMCBham! Great to see so many of our network leads presenting during this afternoon's session!
🚨 Announcing the morning session speaker lineup for #ECMCMeeting25:
✅Patrick Chinnery (@The_MRC) on clinical research workforce decline
✅Christophe Massard & Anna Patrikidou (@gustaveroussy) on France’s CLIP Network
✅Stuart Lavin (@Bayer) on collaborating with the network
Excited to see Prof. Dan Stark (ECMC Leeds & TYA steering committee member) chairing the TYA Projects and Research session at #CCLG2025 The experts are discussing TYA research consent, Outcomes for TYA patients with cancer as well as Fertility research and care in Europe.
It's Day 2 here at @cclguk's annual conference! Diving into more insights on paediatric oncology and clinical research and looking forward to hearing from more experts and latest developments! #CCLG2025#PaediatricOncology
What’s next for CYP oncology research? @kearns_pam from @ECMCBham shares her thoughts at the Insights and Innovations sessions, discussing the future of CYP trials in the UK. #ECMC#CCLG#PaediatricOncology
Help improve treatments and care for future patients with head and neck cancer.
Researchers @ECMC_UK are looking for people with lived experience of head and neck cancer to review their study documents.
Closes: 14 April
https://t.co/I8F2IhV6Rg
Fantastic to be at the #EarlyCareerResearcher Symposium during #CCLG2025. The panel which includes Prof. @kearns_pam from @ECMCBham are discussing navigating complex networks in Paeds and TYA oncology, the power of mentorship, and working with funders!
We're excited to be at @cclguk's annual conference and are looking forward to having insightful conversations about the Paediatric and TYA oncology landscape. Come and chat to Lindsey and Sumair at ECMC stand 13 to hear about our work with children and young adults! #CCLG2025
📢 Join us for our ECMC Network Meeting on 7 May 2025 at Hilton London Bankside! This year’s theme: Meaningful collaboration to drive equitable innovation in #ClinicalTrials. Spaces are limited – register by 20 April. #ECMCMeeting25
🔗 https://t.co/iamE4hukQi
Teenage Cancer Trust Lead Nurse Karen and @CR_UK Senior Research Nurse Ben hosted a visit for Chi Onwurah MP at our unit at the Freeman Hospital in Newcastle today.
(1/3)
Excited to present at #COGUK! @Sandhu1K and Ravi Nizzer are sharing insights from the NCVR pilot, exploring how standardized cost assessments & stronger sponsor-site collaboration are optimising clinical trial value in the UK. #ClinicalResearch#NCVR#OncologyTrials